Find a Clinical Trial
Stories
All news
Glow-tagging the androgen receptor reveals an unexpected vulnerability in advanced prostate cancer
A recent study by a Fred Hutch prostate cancer expert finds potential new drug targets using an innovative tagging method that can be applied to other hormone-driven cancers
February 19, 2026